Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rand Jenkins

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The AAPS Journal|April 30, 2015
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated EnvironmentMarian Kelley, Lauren Stevenson, Michaela Golob, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2015
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometryJosef Pannee, Johan Gobom, Leslie M Shaw, et al.
The AAPS Journal|November 14, 2014
Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeuticsRand Jenkins, Jeffrey X Duggan, Anne-Françoise Aubry, et al.
Biomarkers in Medicine|August 25, 2012
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42Niklas Mattsson, Ingrid Zegers, Ulf Andreasson, et al.
Bioanalysis|April 20, 2012
4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryoverSteve Lowes, Jim Jersey, Ronald Shoup, et al.
Bioanalysis|October 8, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS)Eric Yang, Jan Welink, Stephanie Cape, et al.
Bioanalysis|November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)Jan Welink, Eric Yang, Nicola Hughes, et al.
Bioanalysis|October 11, 2013
2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMSLauren Stevenson, Fabio Garofolo, Binodh DeSilva, et al.
Bioanalysis|December 16, 2014
8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validationJoseph Bower, Douglas Fast, Fabio Garofolo, et al.
Bioanalysis|September 28, 2012
Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC)Steve Lowes, Mark Boterman, Mira Doig, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The AAPS Journal|April 30, 2015
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated EnvironmentMarian Kelley, Lauren Stevenson, Michaela Golob, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2015
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometryJosef Pannee, Johan Gobom, Leslie M Shaw, et al.
The AAPS Journal|November 14, 2014
Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeuticsRand Jenkins, Jeffrey X Duggan, Anne-Françoise Aubry, et al.
Biomarkers in Medicine|August 25, 2012
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42Niklas Mattsson, Ingrid Zegers, Ulf Andreasson, et al.
Bioanalysis|April 20, 2012
4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryoverSteve Lowes, Jim Jersey, Ronald Shoup, et al.
Bioanalysis|October 8, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS)Eric Yang, Jan Welink, Stephanie Cape, et al.
Bioanalysis|November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)Jan Welink, Eric Yang, Nicola Hughes, et al.
Bioanalysis|October 11, 2013
2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMSLauren Stevenson, Fabio Garofolo, Binodh DeSilva, et al.
Bioanalysis|December 16, 2014
8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validationJoseph Bower, Douglas Fast, Fabio Garofolo, et al.
Bioanalysis|September 28, 2012
Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC)Steve Lowes, Mark Boterman, Mira Doig, et al.
Pageof 2